Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 3
2020 1
2021 4
2022 7
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Burden of disease of chronic pain in Colombia.
Lasalvia P, Gil-Rojas Y, Rosselli D. Lasalvia P, et al. Among authors: gil rojas y. Expert Rev Pharmacoecon Outcomes Res. 2022 Dec;22(8):1261-1267. doi: 10.1080/14737167.2022.2125872. Epub 2022 Sep 25. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 36106600
Burden of disease of chronic pain in Ecuador.
Lasalvia P, Gil-Rojas Y, Rosselli D. Lasalvia P, et al. Among authors: gil rojas y. Expert Rev Pharmacoecon Outcomes Res. 2023 Jun;23(5):547-554. doi: 10.1080/14737167.2023.2193689. Epub 2023 Mar 29. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 36946473
Burden of Disease Attributable to Obesity and Overweight in Colombia.
Gil-Rojas Y, Garzón A, Hernández F, Pacheco B, González D, Campos J, Mosos JD, Barahona J, Polania MJ, Restrepo P, Lasalvia P, Castañeda-Cardona C, Rosselli D. Gil-Rojas Y, et al. Value Health Reg Issues. 2019 Dec;20:66-72. doi: 10.1016/j.vhri.2019.02.001. Epub 2019 Apr 28. Value Health Reg Issues. 2019. PMID: 31035116 Free article.
Cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors as combination therapy with metformin in the treatment of type 2 diabetes mellitus without established cardiovascular disease in Colombia.
Lasalvia P, Gil-Rojas Y, García Á. Lasalvia P, et al. Among authors: gil rojas y. Expert Rev Pharmacoecon Outcomes Res. 2022 Sep;22(6):955-964. doi: 10.1080/14737167.2022.2044310. Epub 2022 Mar 8. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 35259045
19 results